N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD

Published:2022-09-24 Issue:1 Volume:17 Page:190-201
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Tang Liang-Jie,Li Gang,Eslam Mohammed,Zhu Pei-Wu,Chen Sui-Dan,Leung Howard Ho-Wai,Huang Ou-Yang,Wong Grace Lai-Hung,Zhou Yu-Jie,Karsdal Morten,Leeming Diana Julie,Jiang Pei,Wang Cong,Yuan Hai-Yang,Byrne Christopher D.,Targher Giovanni,George Jacob,Wong Vincent Wai-Sun,Zheng Ming-Hua^ORCID

Funder

National Natural Science Foundation of China

High Level Creative Talents from Department of Public Health in Zhejiang Province

Southampton NIHR Biomedical Research Centre

Direct Grant from The Chinese University of Hong Kong

National Health and Medical Research Council of Australia

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-022-10420-w.pdf

Reference43 articles.

1. Liu J, Ayada I, Zhang X, Wang L, Li Y, Wen T et al. Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults. Clin Gastroenterol Hepatol. 2022;20:e573–e582

2. Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hep Intl. 2020;14:889–919

3. Zheng KI, Fan JG, Shi JP, Wong VW, Eslam M, George J et al. From NAFLD to MAFLD: a "redefining" moment for fatty liver disease. Chin Med J. 2020;133:2271–2273

4. Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH et al. Global multi-stakeholder endorsement of the MAFLD definition. Lancet Gastroenterol Hepatol. 2022;7:388–390

5. Méndez-Sánchez N, Díaz-Orozco L, Córdova-Gallardo J. Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience. J Hepatoly. 2021;75:221–222

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum dithiothreitol-oxidizing capacity (DOC) is a promising biomarker for excluding significant liver fibrosis: a proof-of-concept study;BMC Medicine;2024-07-02

2. Metabolic dysfunction-associated steatotic liver disease: Evolution of the final terminology;European Journal of Internal Medicine;2024-06

3. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis;BMC Medicine;2024-03-06

4. Serum PRO‐C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort;Liver International;2024-03

5. Reply: Diagnostic accuracy of AGILE3+ score for advanced fibrosis in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis;Hepatology;2023-12-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3